Diagnosis and Classification

The Epidemiology of Diabetes Mellitus: Second Edition

Volumn , Issue , 2008, Pages 11-30

  Ekoé, Jean Marie ^a,b   Zimmet, Paul ^c,d  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^c BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^d MONASH UNIVERSITY   (Australia)

Author keywords

ADA and WHO classification type 1 and type 2; Diabetes and immunological diseases; Diabetes mellitus diagnosis and diagnostic criteria; Diabetes mellitus syndrome classification; Insulin dependent diabetes mellitus (IDDM) or type 1; Noninsulin dependent diabetes mellitus (NIDDM) or type 2; Oral glucose tolerance test (OGTT); Single blood glucose estimation or OGTT diabetes diagnosis; Type 1 cell destruction processes; Type 2 insulin resistance disorders

Indexed keywords

EID: 84889366108     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470779750.ch3     Document Type: Chapter

References (90)

1. World Health Organization (1985) Diabetes melli-tus: report of a WHO study group, Tech. Rep. Ser. 727, WHO, Geneva.
2. Alberti, K.G.M.M. and Zimmet, P. (1998) Definition, diagnosis and classification of diabetes mellitus and its complications part 1: diagnosis and classification of diabetes mellitus-provisional report of a WHO consultation. Diabetic Medicine, 15, 539-53.
3. American Diabetes Association (2006) Diagnosis and classification of diabetes mellitus. Diabetes Care, 29, (Suppl 1), S43-8.
4. Barker, D.J.P., Gardner, M.J. and Power, C. (1982) Incidence of diabetes amongst people aged 18-50 years in nine British towns: a collaborative study. Diabetologia, 22, 421-5.
5. Watkins, P.J. (1979) A new look at diagnostic criteria. Diabetologia, 17, 127-8.
6. Conn, J.W. (1940) Interpretation of the glucose tolerance test: the necessity of a standard preparatory diet. American Journal of the Medical Sciences, 199, 555-64.
7. Conn, J.W. and Fajans, S.S. (1961) The prediabetic state. American Journal of Medicine, 31, 839-50.
8. Soskin, S. (1951) Use and abuse of the dextrose tolerance test. Postgraduate Medicine, 10, 108-16.
9. Sayetta, R.B. and Murphy, R.S. (1979) Summary of current diabetes related data from the National Center for Health Statistics. Diabetes Care, 2, 105-19.
10. Sasaki, A. (1981) Assessment of the new criteria for diabetes mellitus according to 10 year relative survival rates. Diabetologia, 20, 195-8.
11. Finch, C.F., Zimmet, P.Z. and Alberti, K.G.M.M. (1990) Determining diabetes prevalence: a rational basis for the use of fasting plasma glucose concentrations? Diabetic Medicine, 7, 603-10.
12. McCance, D.R., Hanson, R.L., Charles, M.A. et al. (1994) Comparison of tests for glycated haemoglobin and fasting and two hour plasma glucose concentrations as diagnostic methods for diabetes. British Medical Journal, 308, 1323-28.
13. Engelgau, M.M., Thompson, T.J., Herman, W.H. et al. (1997) Comparison of fasting and 2-hour glucose and HbA1c levels for diagnosing diabetes: diagnostic criteria and performance revisited. Diabetes Care, 20, 785-91.
14. Charles, M.A., Balkau, B., Vauzelle-Kervoeden, F. et al. (1996) Revision of diagnostic criteria for diabetes (Letter). Lancet, 348, 1657-8.
15. Harris, M.I., Eastman, R.C., Cowie, C.C. et al. (1997) Comparison of diabetes diagnostic categories in the US population according to 1997 American Diabetes Association and 1980-1985 World Health Organization diagnostic criteria. Diabetes Care, 20, 1859-62.
16. Ramachandran, A., Snehalatha, C., Latha, E. and Vijay V. (1998) Evaluation of the use of fasting plasma glucose as a new diagnostic criterion for diabetes in Asian Indian population (Letter). Diabetes Care, 21, 666-7.
17. WHO Expert Committee (1965) Diabetes mellitus. 1st report, Tech. Rep. Ser. 310, WHO, Geneva.
18. National Diabetes Data Group (1979) Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes, 28, 1039-57.
19. WHO Expert Committee (1980) WHO Expert Committee on Diabetes Mellitus. 2nd report, Tech. Rep. Ser. 646, WHO, Geneva.
20. Ekoé, J.M. and Shipp, J. (2001) Malnutrition-related diabetes mellitus. Myth or reality, in The Epidemiology of Diabetes Mellitus. An International Perspective, 1st edn (eds J.M. Ekoe, P. Zimmet and R. Williams), John Wiley & Sons, Ltd, Chichester, pp. 263-72.
21. Kuzuya, T. and Matsuda, A. (1997) Classification of diabetes on the basis of etiologies versus degree of insulin deficiency. Diabetes Care, 20, 1185-97.
22. Shaw, J.E., Zimmet, P.Z., de Courten, M. et al. (1999) Impaired fasting glucose or impaired glucose tolerance. What best predicts future diabetes in Mauritius? Diabetes Care, 22 (3), 399-402.
23. Fuller, J.H., Shipley, M.J., Rose, G. et al. (1980) Coronary heart disease risk and impaired glucose tolerance: the Whitehall Study. Lancet, i, 1373-6.
24. Alberti, K.G.M.M. (1996) The clinical implications of impaired glucose tolerance. Diabetic Medicine, 13, 927-37.
25. Reaven, G.M. (1988) Role of insulin resistance in human disease. Diabetes, 37, 1595-607.
26. Zimmet, P.Z., Tuomi, T., Mackay, R. et al. (1994) Latent autoimmune diabetes mellitus in adults (LADA): the role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency. Diabetic Medicine, 11, 299-303.
27. Humphrey, A.R.G., McCarty, D.J., Mackay, I.R. et al. (1998) Autoantibodies to glutamic acid decarboxylase and phenotypic features associated with early insulin treatment in individuals with adult-onset diabetes mellitus. Diabetic Medicine, 15, 113-19.
28. Verge, C.F., Gianani, R., Kawasaki, E., et al. (1996) Predicting type 1 diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes, 45, 926-33.
29. Molbak, A.G., Christau, B., Marner, B. et al. (1994) Incidence of insulin-dependent diabetes mellitus in age groups over 30 years in Denmark. Diabetic Medicine, 11, 650-5.
30. Betterle, C., Zanette, F., Pedini, B. et al. (1983) Clinical and subclinical organ-specific autoimmune manifestations in type 1 (insulin-dependent) diabetic patients and their first-degree relatives. Dia-betologia, 26, 431-6.
31. McLarty, D.G., Athaide, I., Bottazzo, G.F. et al. (1990) Islet cell antibodies are not specifically associated with insulin-dependent diabetes in rural Tanzanian Africans. Diabetes Research and Clinical Practice, 9, 219-24.
32. Ahrén, B. and Corrigan, C.B. (1984) Intermittent need for insulin in a subgroup of diabetic patients in Tanzania. Diabetic Medicine, 2, 262-4.
33. DeFronzo, R.A., Bonadonna, R.C. and Ferrannini, E. (1997) Pathogenesis of NIDDM, in International Textbook of Diabetes Mellitus, 2nd edn (eds K.G.M.M. Alberti, P. Zimmet and R.A. De Fronzo), John Wiley & Sons, Ltd, Chichester, pp. 635-712.
34. Lillioja, S., Mott, D.M., Spraul, M. et al. (1993) Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes. Prospective study of Pima Indians. The New England Journal of Medicine, 329, 1988-92.
35. Campbell, P.J. and Carlson, M.G. (1993) Impact of obesity on insulin action in NIDDM. Diabetes, 42, 405-10.
36. Bogardus, C., Lillioja, S., Mott, D.M. et al. (1985) Relationship between degree of obesity and in vivo insulin action in man. The American Journal of Physiology, 248, E286-91.
37. Kissebah, A.H., Vydelingum, N., Murray, R. et al. (1982) Relationship of body fat distribution to metabolic complications of obesity. The Journal of Clinical Endocrinology and Metabolism, 54, 254-60.
38. Banerji, M.A., Chaiken, R.I., Huey, H. et al. (1994) GAD antibody negative NIDDM in adult black subjects with diabetic ketoacidosis and increased frequency of human leukocyte antigen DR3 and DR4: flatbush diabetes. Diabetes, 43, 741-5.
39. Umpierrez, G.E., Casals, M.M.C., Gebhardt, S.S.P. et al. (1995) Diabetic ketoacidosis in obese African-Americans. Diabetes, 44, 790-5.
40. Simonson, D.C., Ferrannini, E., Bevilacqua, S. et al. (1984) Mechanism of improvement in glucose metabolism after chronic glyburide therapy. Diabetes, 33, 838-45.
41. Wing, R.R., Blair, E.H., Bononi, P. et al. (1994) Caloric restriction per se is a significant factor in improvements in glycemic control and insulin sensitivity during weight loss in obese NIDDM patients. Diabetes Care, 17, 30-6.
42. Zimmet, P.Z. (1992) Kelly West Lecture 1991: challenges in diabetes epidemiology: from West to the rest. Diabetes Care, 15, 232-52.
43. Harris, M.I., Cowie, C.C., Stern, M.P. et al. (eds) (1995) Diabetes in America, 2nd edn, NIH Publ. No. 95-1468, US Government Printing Office, Washington, DC.
44. Valle, T., Tuomilehto, J. and Eriksson, J. (1997) Epi-demiology of NIDDM in Europids, in International Textbook of Diabetes Mellitus, 2nd edn (eds K.G.M.M. Alberti, P. Zimmet and R.A. De Fronzo), John Wiley & Sons, Ltd, Chichester, pp. 125-42.
45. De Courten, M., Bennett, P.H., Tuomilehto, J. and Zimmet, P. (1997) Epidemiology of NIDDM in non-Europids, in International Textbook of Diabetes Mellitus, 2nd edn (eds K.G.M.M. Alberti, P. Zimmet and R.A. De Fronzo), John Wiley & Sons, Ltd, Chichester, pp. 143-70.
46. Knowler, W.C., Nelson, R.G., Saad, M., et al. (1943) Determinants of diabetes mellitus in the Pima Indians. Diabetes Care, 16, 216-27.
47. Byrne, M.M., Sturis, J., Menzel, S. et al. (1996) Altered insulin secretory response to glucose in diabetic and nondiabetic subjects with mutations in the diabetes susceptibility gene MODY 3 on chromosome 20. Diabetes, 45, 1503-10.
48. Clement, K., Pueyo, M.E., Vaxillaire, M. et al. (1996) Assessment of insulin sensitivity in glucokinase-deficient subjects. Diabetologia, 39, 82-90.
49. Yamagata, K., Oda, N., Kaisaki, P.J. et al. (1996) Mutations in the hepatocyte nuclear factor-1α gene in maturity-onset diabetes of the young (MODY 3). Nature, 384, 455-8.
50. Froguel, P., Vaxillaire, M., Sun, F. et al. (1992) Close linkage of glucokinase locus on chromosome 7p to early-onset non-insulin-dependent diabetes. Nature, 356, 162-4.
51. Vionnet, N., Stoffel, M., Takeda, J. et al. (1992) Nonsense mutation in the glucokinase gene causes early-onset non-insulin-dependent diabetes. Nature, 356, 721-2.
52. Yamagata, K., Furuta, H., Oda, N. et al. (1996) Mutations in the hepatocyte nuclear factor-4α gene in maturity-onset diabetes of the young (MODY 1). Nature, 384, 458-60.
53. Stoffers, D.A., Ferrer, J., Clarke, W.L. et al. (1997) Early-onset type-II diabetes mellitus (MODY4) linked to IPF1. Nature Genetics, 117, 138-9.
54. Walker, M. and Turnbull, D.M. (1997) Mitochondrial related diabetes: a clinical perspective. Diabetic Medicine, 14, 1007-9.
55. Johns, D.R. (1995) Mitochondrial DNA and disease. The New England Journal of Medicine, 333, 638-44.
56. Gruppuso, P.A., Gorden, P., Kahn, C.R. et al. (1984) Familial hyperproinsulinemia due to a proposed defect in conversion of proinsulin to insulin. The New England Journal of Medicine, 311, 629-34.
57. Robbins, D.C., Shoelson, S.E., Rubenstein, A.H. et al. (1984) Familial hyperproinsulinemia: two cohorts secreting indistinguishable type II intermediates of proinsulin conversion. Journal of Clinical Investigation, 73, 714-19.
58. Haneda, M., Polonsky, K.S., Bergenstal, R.M. et al. (1984) Familial hyperinsulinemia due to a structurally abnormal insulin. Definition of an emerging new clinical syndrome. The New England Journal of Medicine, 310, 1288-94.
59. Sanz, N., Karam, J.H., Horita, S. et al. (1986) Prevalence of insulin-gene mutations in non-insulin-dependent diabetes mellitus. The New England Journal of Medicine, 314, 1322-3.
60. Kahn, C.R., Flier, J.S., Bar, R.S. et al. (1976) The syndromes of insulin resistance and acanthosis nigricans. The New England Journal of Medicine, 294, 739-45.
61. Taylor, S.I. (1992) Lilly Lecture: molecular mechanisms of insulin resistance: lessons from patients with mutations in the insulin-receptor gene. Diabetes, 41, 1473-90.
62. Gullo L., Pezzilli, R., and Morselli-Labate A.M. (1994) Diabetes and the risk of pancreatic cancer. The New England Journal of Medicine, 331, 81-4.
63. Larsen, S., Hilsted, J., Tronier, B. et al. (1987) Metabolic control and B cell function in patients with insulin-dependent diabetes mellitus secondary to chronic pancreatitis. Metabolism, 36, 964-7.
64. Moran, A., Pyzdrowski, K.L., Weinreb, J. et al. (1994) Insulin sensitivity in cystic fibrosis. Diabetes, 43, 1020-6.
65. Phelps, G., Chapman, I., Hall, P. et al. (1989) Prevalence of genetic haemochromatosis among diabetic patients. Lancet, ii, 233-4.
66. Yajnik, C.S., Shelgikar, K.M., Naik, S.S. et al. (1992) The ketoacidosis-resistance in fibro-calculous-pancreatic-diabetes. Diabetes Research and Clinical Practice, 15, 149-56.
67. MacFarlane, I.A. (1997) Endocrine diseases and diabetes mellitus, in Textbook of Diabetes, 2nd edn (eds J.C. Pickup and G. Williams), Blackwell Science, Oxford, pp. 64.1-20.
68. Krejs, G.J., Orci, L., Conion, J.M. et al. (1979) Somatostatinoma syndrome. The New England Journal of Medicine, 301, 285-92.
69. Conn, J.W. (1965) Hypertension, the potassium ion and impaired carbohydrate tolerance. The New England Journal of Medicine, 273, 1135-43.
70. Pandit, M.K., Burke, J., Gustafson, A.B. et al. (1993) Drug-induced disorders of glucose tolerance. Annals of Internal Medicine, 118, 529-40.
71. O'Byrne, S. and Feely, J. (1990) Effects of drugs on glucose tolerance innon-insulin-dependent diabetes (parts I and II). Drugs, 40, 203-19.
72. Gallanosa, A.G., Spyker, D.A. and Curnow, R.T. (1981) Diabetes mellitus associated with autonomic and peripheral neuropathy after Vacor poisoning: a review. Clinical Toxicology, 18, 441-9
73. Esposti, M.D., Ngo, A. and Myers, M.A. (1996) Inhibition of mitochondrial complex 1 may account for IDDM induced by intoxication with rodenticide Vacor. Diabetes, 45, 1531-4.
74. Assan, R., Perronne, C., Assan, D. et al. (1995) Pentamidine-induced derangements of glucose homeostasis. Diabetes Care, 18, 47-55.
75. Forrest, J.A., Menser, M.A. and Burgess, J.A. (1971) High frequency of diabetes mellitus in young patients with congenital rubella. Lancet, ii, 332-4.
76. King, M.L., Bidwell, D., Shaikh, A. et al. (1983) Coxsackie-B-virus-specific IgM responses in children with insulin-dependent (juvenile-onset; type 1) diabetes mellitus. Lancet, i, 1397-9.
77. Karjalainen, J., Knip, M., Hyoty, H. et al. (1988) Relationship between serum insulin antibodies, islet cell antibodies and Coxsackie-B4 and mumps virus-specific antibodies at the clinical manifestation of type 1 (insulin-dependent) diabetes. Diabetologia, 31, 146-52.
78. Pak, C.Y., Eun, H., McArthur, R.G. et al. (1988) Association of cytomegalovirus infection with autoimmune type 1 diabetes. Lancet, ii, 1-4.
79. Fabris, P., Betterle, C., Floreani, A. et al. (1992) Development of type 1 diabetes mellitus during interferon alfa therapy for chronic HCV hepatitis (Letter). Lancet, 340, 548.
80. Flier, J.S. (1992) Lilly Lecture: syndromes of insulin resistance: from patient to gene and back again. Diabetes, 41, 1207-19.
81. Khan, C.R., Baird, K.L., Flier, J.S. et al. (1977) Effects of autoantibodies to the insulin receptor on isolated adipocytes. Journal of Clinical Investigation, 60, 1094-106.
82. Tsokos, G.C., Gorden, P., Antonovych, T. et al. (1985) Lupus nephritis and other autoimmune features in patients with diabetes mellitus due to autoantibody to insulin receptors. Annals of Internal Medicine, 102, 176-81.
83. Barrett, T.G., Bundey, S.E. and Macleod, A.F. (1995) Neurodegeneration and diabetes: UK nationwide study of Wolfram (DIDMOAD) syndrome. Lancet, 346, 1458-63.
84. Carpenter, M.W. and Coustan, D.R. (1982) Criteria for screening tests for gestational diabetes. American Journal of Obstetrics and Gynecology, 144, 768-73.
85. Bodansky, H.J., Grant, P.J., Dean, B.M. et al. (1986) Islet-cell antibodies and insulin autoantibodies in association with common viral infections. Lancet, ii, 1351-3.
86. Hirata, Y., Ishizu, H., Ouchi, N. et al. (1970) Insulin autoimmunity in a case of spontaneous hypoglycaemia. The Joumal of the Japan Diabetes Society, 13, 312-20.
87. McCance, D.R., Hanson, R.L., Pettitt, D.J. et al. (1997) Diagnosing diabetes mellitus-do we need new criteria? Diabetologia, 40, 247-55.
88. O'Sullivan, J.B. and Mahan, C.M. (1964) Criteria for the oral glucose tolerance test in pregnancy. Diabetes, 13, 278.
89. Permert, J., Larsson, J., Westermark, G.T. et al. (1994) Islet amyloid polypeptide in patients with pancreatic cancer and diabetes. The New England Journal of Medicine, 330, 313-18.
90. Solimena, M. and De Camilli, P. (1991) Autoimmunity to glutamic acid decarboxylase (GAD) in stiff-man syndrome and insulin-dependent diabetes mellitus. Trends in Neurosciences, 14, 452-7.